Photo 36897570 © Sherry Young |
Dreamstime Xxl 36897570

Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine

May 31, 2023
Johns Hopkins Medicine–led team shows technique can find protein fragments that best stimulate the immune system to recognize and attack the virus.
Courtesy of the CDC
Courtesy of the CDC

HIV declines among young people and drives overall decrease in new HIV infections

May 25, 2023
Increased investments, innovation, and focus on equity are vitally needed to end the HIV epidemic.
Photo 165320191 © Jarun011 |
Dreamstime Xxl 165320191
Photo 186155331 © Noipornpan |
Dreamstime Xxl 186155331
Photo 96831347 © Jarun011 |
Dreamstime Xxl 96831347
Courtesy of the CDC

HIV can persist for years in myeloid cells of people on antiretroviral therapy

March 28, 2023
NIH-funded study confirms white blood cell subtype as HIV reservoir, suggests new target for cure efforts.
Courtesy of the CDC
S0314 Vs Hiv Treatment
Photo 95973145 © Guernica |
Dreamstime Xxl 95973145

Long-acting antiretroviral therapy suppresses HIV among people with unstable housing, mental illnesses, substance use disorders

Feb. 22, 2023
NIH-supported study demonstrates injectable ART may improve outcomes in underserved patients.
Photo 113230282 © Juan Moyano |
Dreamstime Xxl 113230282

Shifting HIV focus from at-risk populations to at-risk behavior

Jan. 23, 2023
Since 2015, only about 1.2 million people have been considered ‘at risk’ of HIV and potentially able to benefit from pre-exposure prophylaxis, also known as PrEP, according to...
Courtesy of NIAID, NIH
Transmission electron micrograph of HIV-1 virus particles (red) budding and replicating from a segment of a chronically infected H9 cell (blue). Particles are in various stages of maturity; arc/semi-circles are immature particles that have started to form but are still part of the cell. Immature particles slowly change morphology into mature forms and exhibit the classic “conical or spherical-shap, NIAID.

Experimental HIV vaccine regimen safe but ineffective, study finds

Jan. 19, 2023
The clinical trial began in 2019 and involved 3,900 volunteers.